Headache (12), fatigue (7), exacerbation of Crohn’s disease (5), dizziness (5), nausea (5), DNA or ANA antibody positive (7), dyspexia (4), abdominal pain (3), arthralgia (3), backpain (3), insomnia (3), pyrexia (3), sinopulmonary infections (8). This evidence concerns the gene BTG3 and Crohn disease.